Evidence map›Paper›PMID 29260263›Full record

SynthesisPediatric cardiology2018

Systematic Literature Review on the Incidence and Prevalence of Heart Failure in Children and Adolescents.

Robert E Shaddy, Aneesh Thomas George, Thomas Jaecklin, Eimear Nic Lochlainn, Lalit Thakur, Rumjhum Agrawal, Susan Solar-Yohay, Fabian Chen, Joseph W Rossano, Thomas Severin and 1 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Pediatric cardiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Robert E ShaddyChildren's Hospital Los Angeles, 4650 Sunset Blvd. MS#126, Los Angeles, CA, 90027, USA. rshaddy@chla.usc.edu.
Aneesh Thomas GeorgeNovartis Healthcare Pvt. Ltd., Hyderabad, India.
Thomas JaecklinShire International GmbH, Global Clinical Development, Zählerweg 10, 6300, Zug, Switzerland.
Eimear Nic LochlainnNovartis Pharma AG, Basel, Switzerland.
Lalit ThakurNovartis Healthcare Pvt. Ltd., Hyderabad, India.
Rumjhum AgrawalNovartis Healthcare Pvt. Ltd., Hyderabad, India.
Susan Solar-YohayNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Fabian ChenNovartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Joseph W RossanoChildren's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Thomas SeverinNovartis Pharma AG, Basel, Switzerland.
Michael BurchCardiorespiratory Division, Great Ormond Street Hospital for Children, London, UK.
Novartis (India) · INNovartis (Switzerland) · CHNovartis (United States) · USChildren's Hospital of Los Angeles · USChildren's Hospital of Philadelphia · USGreat Ormond Street Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the epidemiology of adult heart failure has been extensively researched, this systematic review addresses the less well characterized incidence and prevalence of pediatric HF. The search strategy used Cochrane methodology and identified 83 unique studies for inclusion. Studies were categorized according to whether the HF diagnosis was reported as primary (n = 10); associated with other cardiovascular diseases (CVDs) (n = 49); or associated with non-CVDs (n = 24). A narrative synthesis of the evidence is presented. For primary HF, the incidence ranged from 0.87/100,000 (UK and Ireland) to 7.4/100,000 (Taiwan). A prevalence of 83.3/100,000 was reported in one large population-based study from Spain. HF etiology varied across regions with lower respiratory tract infections and severe anemia predominating in lower income countries, and cardiomyopathies and congenital heart disease major causes in higher income countries. Key findings for the other categories included a prevalence of HF associated with cardiomyopathies ranging from 36.1% (Japan) to 79% (US); associated with congenital heart disease from 8% (Norway) to 82.2% (Nigeria); associated with rheumatic heart diseases from 1.5% (Turkey) to 74% (Zimbabwe); associated with renal disorders from 3.8% (India) to 24.1% (Nigeria); and associated with HIV from 1% (US) to 29.3% (Brazil). To our knowledge, this is the first systematic review of the topic and strengthens current knowledge of pediatric HF epidemiology. Although a large body of research was identified, heterogeneity in study design and diagnostic criteria limited the ability to compare regional data. Standardized definitions of pediatric HF are required to facilitate cross-regional comparisons of epidemiological data.

Indexed as

AdolescentChildChild, PreschoolHeart FailureHumansIncidenceInfantPrevalenceRisk FactorsEpidemiologyHeart failureIncidencePediatricPrevalenceSystematic

Identifiers

PMID29260263
PMCPMC5829104
OpenAlexW2780002035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.